FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $81,519 | -73.0% | 28,603 | -30.9% | 0.01% | -77.6% |
| Q4 2022 | $301,414 | -20.9% | 41,403 | +206.2% | 0.05% | +81.5% |
| Q3 2021 | $381,000 | +101.6% | 13,523 | -24.9% | 0.03% | +125.0% |
| Q2 2021 | $189,000 | -21.2% | 18,000 | -11.5% | 0.01% | -29.4% |
| Q1 2021 | $240,000 | -13.7% | 20,343 | -14.2% | 0.02% | -10.5% |
| Q4 2020 | $278,000 | – | 23,710 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |